Transaction DateRecipientSharesTypePriceValue
3rd August 2020Randall Shultz700Open or private purchase$3.16$2,212.00
3rd August 2020Pamela Haley700Open or private purchase$3.16$2,212.00
3rd February 2020Sarah Reiter700Open or private purchase$1.72$1,204.00
3rd February 2020Pamela Haley700Open or private purchase$1.72$1,204.00
3rd February 2020Matthew T Plavan700Open or private purchase$1.72$1,204.00
23rd December 2019Sarah Reiter900Open or private purchase$5.95$5,355.00
19th November 2019Sarah Reiter1,000Open or private purchase$4.52$4,520.00
18th November 2019Lilian Shackelford Murray5,000Open or private purchase$4.25$21,250.00
14th November 2019Matthew T Plavan1,000Open or private purchase$4.08$4,079.50
23rd September 2019Matthew T Plavan2,000Open or private purchase$5.25$10,500.00
Arcadia Biosciences
Arcadia Biosciences logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Arcadia Biosciences, Inc. is an agricultural biotechnology company. It uses screening, breeding, and biotechnology techniques to create agricultural products. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.

Ticker: RKDA
Sector: Process Industries
Industry: Chemicals: Agricultural
SEC Central Index Key (CIK): 1469443
Employees: 61
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags